Antiviral combination therapy with hematopoietic agent

This page covers all Antiviral combination therapy with hematopoietic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interferon-α receptor; viral RNA polymerase; erythropoietin receptor.

Targets

Interferon-α receptor; viral RNA polymerase; erythropoietin receptor

Marketed (1)

• Peginterferon alfa-2a, Ribavirin, epoetin-β · Germans Trias i Pujol Hospital · Virology/Hepatology
  This combination therapy enhances immune response against hepatitis C virus while supporting red blood cell production to counteract treatment-induced anemia.

Patent intelligence

• antiviral combination therapy with hematopoietic agent patent landscape — aggregated cliff calendar, attackable patents, originator estates